
Inflix Pharma Private Limited
About Inflix Pharma Private Limited
Data last updated:
Inflix Pharma Private Limited is a private limited company based in Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24239UP2021PTC154527. Its GSTIN is 09AAGCI3770A1ZR (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saira Bano and Manoj Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.40 Panchkula 3rd Colony Chhapraula Dadri, Noida, Uttar Pradesh, India – 201001.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.97 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹10,494 (net margin 0.6%) and EBITDA of ₹20,000 (EBITDA margin 1.2%).
Inflix Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0034366).
Company details
Recognitions & Rankings of Inflix Pharma
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-28-0034366
Contact details
Inflix Pharma Private Limited's registered office is in Noida, Uttar Pradesh.
- Registered AddressHouse No.40 Panchkula 3rd Colony Chhapraula Dadri, Noida, Uttar Pradesh, India – 201001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inflix Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inflix Pharma Private Limited, buy the company report.
Financials of Inflix Pharma Private Limited
FY 2025 filings availableInflix Pharma Private Limited reported revenue of ₹16.97 Lakh (down 39% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 39% in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹20,000 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹10,494 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.2% | |||
| Net Profit Margin | 0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Inflix Pharma Private Limited, buy the company report.
Board of directors of Inflix Pharma Private Limited
Inflix Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saira Bano | Director | 25 Oct 2021 | 5 Years 0 Months | Current |
| Manoj Kumar | Director | 25 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Inflix Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tradetree Global Private Limited | ₹16.98 Lakh (FY 2021) | -68.0% | Noida, Uttar Pradesh, India | |||
| Blackhawk Med Private Limited | ₹16.98 Lakh (FY 2023) | 579.0% | Lucknow, Uttar Pradesh, India | |||
| Unisars Health Care Private Limited | ₹16.98 Lakh (FY 2025) | -87.0% | Agra, Uttar Pradesh, India | |||
| Watech Chemicals Private Limited | ₹16.97 Lakh (FY 2024) | 5.0% | Chennai, Tamil Nadu, India | |||
| Tiptop Traders Pvt Ltd | ₹16.97 Lakh (FY 2024) | -8.0% | Kolkata, West Bengal, India | |||
| Inflix Pharma Private Limitedthis company | ₹16.97 Lakh (FY 2025) | ₹10,494 | 0.6% | -39.0% | Noida, Uttar Pradesh, India | |
| Yoravis Trading Private Limited | ₹16.97 Lakh (FY 2022) | Thane, Maharashtra, India | ||||
| Shivmangal Vinimay Private Limited | ₹16.97 Lakh (FY 2024) | -8.0% | Kolkata, West Bengal, India | |||
| Medlandos Pharmaceuticals Private Limited | ₹16.97 Lakh (FY 2023) | -63.0% | Salem, Tamil Nadu, India | |||
| Balaji Bio Plantteec Tecnology Private Limited (OPC) | ₹16.97 Lakh (FY 2023) | 317.0% | Samastipur, Bihar, India | |||
| S.P.G Fertilizers Private Limited | ₹16.96 Lakh (FY 2025) | -78.0% | Hooghly, West Bengal, India |
To see the full peer comparison of Inflix Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inflix Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inflix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inflix Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCI3770A1ZR | Uttar Pradesh | Active | 10 Feb 2022 |
To see the full GST registrations and return filing status of Inflix Pharma Private Limited, buy the company report.
Recent activity
Inflix Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Manoj Kumar was appointed as Director on 25 Oct 2021.
Frequently asked questions
Inflix Pharma is an active private limited company based in Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 October 2021 (5+ years old) and is registered under CIN U24239UP2021PTC154527.
Inflix Pharma has 2 current directors:
- Saira Bano - Director
- Manoj Kumar - Director
The latest financial statements of Inflix Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Inflix Pharma is 09AAGCI3770A1ZR, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Inflix Pharma is U24239UP2021PTC154527. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inflix Pharma was incorporated on 25 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Inflix Pharma by revenue are Tradetree Global Private Limited, Blackhawk Med Private Limited, Unisars Health Care Private Limited, Watech Chemicals Private Limited, Tiptop Traders Pvt Ltd and 5 more, all in the same principal business activity (wholesale trading).
Manoj Kumar was appointed as Director on 25 Oct 2021. Saira Bano was appointed as Director on 25 Oct 2021.
Yes, Inflix Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Inflix Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0034366).
The registered office of Inflix Pharma is at House No.40 Panchkula 3rd Colony Chhapraula Dadri, Noida, Uttar Pradesh, India – 201001.

